YOLFTbeta
IHH Healthcare Bhd

IHH Healthcare Bhd

5225 · KLSE · Healthcare / Medical Care Facilities

7.93MYR+0.09 (+1.15%)

Price History

Full chart

Market Stats

Previous Close7.84
Open7.76
Day Range7.76 – 8.00
52-Week Range7.49 – 9.46
Volume1.65M
Market Cap69.36B
P/E (TTM)31.40
Forward P/E28.25
EPS0.25
Dividend Yield1.40%
Beta0.16
50-Day Avg7.94
200-Day Avg8.53

About

IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specialist consultative care, advanced treatment, complex surgery, and inpatient care services; and quaternary care services, such as organ transplants, neurosurgery, cardiac surgery, and reconstructive plastic surgery; and complementary ancillary services. It also engages in the provision of catering, laundry, and cleaning services for hospitals, as well as services of preparation and serving food; supervise and manage the construction of healthcare facilities; conduct research, develop, and market healthcare information systems, web-based applications, and other technology solutions; e-consulting and marketplace activities relating to all health-related products; import and wholesale of drug and medical materials; and operates pharmacy. In addition, the company provides facility management and building maintenance; clinical research; rehabilitation; administrative support; comprehensive professional oncological services, such as diagnostic, radiotherapy, and chemotherapy treatment; courses in nursing and allied health; agent and administrator for managed care and related services; and computer software designing development, customization, integration, implementation, maintenance, and related services. Further, it is involved in development, construction, and leasing of medical facility buildings; retail sale of pharmaceutical, medical, and orthopaedic goods; and property development. IHH Healthcare Berhad was incorporated in 2010 and is based in Kuala Lumpur, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Prem Kumar Nair
  • Employees76.00K
  • HeadquartersMercu Aspire, Kuala Lumpur, Malaysia, 59200, Malaysia
  • Websitehttps://www.ihhhealthcare.com

Leadership

  • Dr. Prem Kumar NairGroup Chief Executive Officer · b. 1961
  • Mr. Dilip KadambiGroup Chief Financial Officer · b. 1974
  • Ms. Ida Suryati binti Ab RahimGroup General Counsel · b. 1973
  • Ms. Sook Yean FooGroup Chief Human Resource Officer · b. 1972
  • Ms. Nili Shayrina binti SaatGroup Chief Risk Officer · b. 1975
  • Mr. Stephen John ByrneGroup Chief Internal Audit Officer · b. 1973
  • Mr. Ashok PanditGroup Chief Corporate Officer · b. 1965
  • Dr. Chorng Ann ChowChief Executive Officer of IHH Healthcare Singapore · b. 1975
  • Dr. Hing Lim TsangRegional Chief Executive Officer of IHH Healthcare North Asia · b. 1970
  • Associate Prof. Hsiu Chin LimGroup Chief Medical Officer · b. 1974

Financials

Income Statement

Currency: MYR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.95B4.51B5.19B6.98B6.75B7.34B8.45B10.01B11.14B11.52B14.91B13.40B17.13B17.99B20.93B24.38B25.75B
Growth (%)-+14.20%+15.18%+34.44%-3.24%+8.69%+15.10%+18.54%+11.25%+3.38%+29.44%-10.12%+27.83%+5.02%+16.38%+16.47%+5.59%
Cost of Revenue1.23B1.37B1.61B2.62B1.85B1.89B2.18B2.68B3.01B3.16B4.51B4.10B5.14B5.50B6.24B6.82B19.12B
Gross Profit2.72B3.14B3.59B4.36B4.90B5.45B6.26B7.33B8.13B8.36B10.40B9.30B11.99B12.49B14.70B17.56B6.63B
Gross Margin68.84%69.65%69.07%62.49%72.58%74.20%74.16%73.22%72.94%72.57%69.76%69.43%69.99%69.44%70.20%72.03%25.74%
Operating Expense2.28B3.02B2.93B3.35B3.76B4.12B4.74B5.95B6.32B6.82B8.71B8.33B9.40B9.79B10.44B13.53B3.27B
Operating Income434.04M117.86M652.45M1.01B1.14B1.33B1.52B1.38B1.80B1.54B1.69B973.57M2.59B2.70B4.26B4.03B3.35B
Operating Margin11.00%2.62%12.57%14.54%16.95%18.12%18.01%13.80%16.18%13.37%11.31%7.27%15.10%15.00%20.34%16.53%13.02%
EBITDA49.47M654.69M787.70M1.73B1.60B2.01B2.07B1.88B2.45B2.00B2.94B2.45B4.32B4.10B6.28B6.28B5.24B
EBITDA Margin1.25%14.53%15.17%24.84%23.69%27.38%24.45%18.78%22.01%17.37%19.74%18.29%25.19%22.78%30.00%25.74%20.35%
Net Income463.55M78.72M245.66M798.89M631.16M754.29M933.90M612.35M969.95M627.69M551.48M199.04M1.86B1.55B2.95B2.66B2.10B
Net Income Margin11.75%1.75%4.73%11.45%9.35%10.28%11.06%6.12%8.71%5.45%3.70%1.49%10.87%8.61%14.10%10.90%8.16%
R&D---944.55M2.41M------------
R&D as % of Total Revenue---13.53%0.04%------------
Interest Expense366.87M306.49M83.89M161.26M117.05M120.23M158.31M194.61M277.20M283.68M563.06M466.46M444.56M471.66M747.38M848.00M1.06B
Interest Expense % of Total Revenue9.30%6.80%1.62%2.31%1.73%1.64%1.87%1.94%2.49%2.46%3.78%3.48%2.60%2.62%3.57%3.48%4.14%

Balance Sheet

Currency: MYR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.51B15.76B23.02B23.29B27.26B28.64B35.50B37.19B38.92B45.11B45.05B44.53B45.51B48.47B51.25B56.76B57.62B
Total Liabilities187.99M12.63B6.12B5.07B7.34B7.33B11.26B13.29B13.02B16.61B16.96B17.50B18.23B19.31B18.90B22.85B23.52B
Total Equity2.31B2.87B16.30B17.25B18.08B19.45B22.16B21.99B24.05B24.15B24.50B23.90B24.58B26.19B29.11B30.14B30.30B
Cash42.84M1.17B1.77B1.49B2.14B2.46B1.98B2.44B6.08B7.76B4.71B4.19B5.02B1.83B2.38B1.51B1.59B
Total Debt125.90M6.71B3.04B2.63B4.46B4.27B6.70B7.49B7.64B10.57B11.10B11.63B10.87B10.83B10.05B14.78B15.54B
Net Debt83.06M5.54B1.28B1.14B2.32B1.80B4.72B5.05B715.24M2.77B6.38B7.44B5.86B9.01B7.67B13.27B13.94B

Cash Flow

Currency: MYR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow35.31M398.76M1.36B1.17B1.34B1.63B1.99B1.93B2.26B1.86B2.45B2.44B3.53B3.67B3.42B4.29B5.05B
Investing Cash Flow-14.82M-5.96B-2.27B-1.65B-1.57B-745.87M-3.38B-1.67B-164.35M-3.23B-2.59B-2.08B-821.69M-1.85B-1.77B-8.25B-4.55B
Financing Cash Flow2.72M6.92B1.32B684.43M792.65M-524.50M802.00M153.75M1.64B928.39M-2.92B-860.06M-1.79B-2.92B-2.82B3.03B-303.00M
Capital Expenditure15.44M187.51M884.56M911.84M1.44B920.01M1.37B2.29B1.51B1.06B1.08B904.20M1.07B1.72B1.94B3.24B3.45B
Free Cash Flow19.87M211.26M471.47M253.84M-102.53M710.59M612.91M-354.25M754.82M803.02M1.37B1.54B2.46B1.95B1.48B1.05B1.60B
Dividends Paid11.43M8.78M2.13M--163.50M246.65M246.94M247.17M247.34M263.22M350.96M351.16M528.16M1.77B881.00M927.00M
FCF to OCF56.27%52.98%34.77%21.78%-7.66%43.58%30.87%-18.32%33.39%43.07%55.79%63.02%69.68%53.21%43.16%24.41%31.78%
Dividend Paid to FCF57.54%4.15%0.45%--23.01%40.24%-69.71%32.75%30.80%19.28%22.78%14.27%27.07%119.93%84.23%57.76%

Earnings

Report DateAug 28, 2012Nov 28, 2012Feb 25, 2013May 23, 2013Aug 27, 2013Nov 25, 2013Feb 27, 2014May 29, 2014Aug 28, 2014Nov 25, 2014Feb 26, 2015May 28, 2015Aug 26, 2015Nov 26, 2015Feb 25, 2016May 26, 2016Aug 25, 2016Nov 24, 2016Feb 23, 2017May 19, 2017Aug 23, 2017Nov 27, 2017Feb 27, 2018May 25, 2018Aug 28, 2018Nov 27, 2018Feb 27, 2019May 30, 2019Aug 30, 2019Nov 29, 2019Feb 28, 2020Jun 29, 2020Aug 27, 2020Nov 26, 2020Feb 26, 2021May 31, 2021Aug 26, 2021Nov 29, 2021Feb 23, 2022May 26, 2022Aug 25, 2022Nov 29, 2022Feb 28, 2023May 31, 2023Aug 29, 2023Nov 30, 2023Feb 29, 2024May 29, 2024Aug 29, 2024Nov 28, 2024Feb 26, 2025May 29, 2025Aug 29, 2025Nov 26, 2025Feb 27, 2026May 26, 2026Aug 27, 2026Nov 25, 2026
EPS Estimate0.020.020.030.020.020.020.020.020.030.020.030.030.030.030.030.030.030.030.040.040.050.020.020.030.050.040.020.040.040.030.03--0.040.020.040.040.040.050.050.040.050.060.040.040.050.050.040.040.040.060.070.060.060.060.060.060.060.07
EPS Actual0.050.010.020.020.020.020.020.020.020.020.030.030.030.030.030.030.020.030.030.020.010.010.020.010.030.030.040.020.020.020.03-0.04-0.010.020.040.040.050.040.050.040.030.040.040.040.040.040.030.050.050.060.040.050.050.050.060.050.06-
Surprise150.00%-50.00%-33.33%0.00%0.00%0.00%0.00%0.00%-33.33%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-33.33%0.00%-25.00%-50.00%-80.00%-50.00%0.00%-66.67%-40.00%-25.00%100.00%-50.00%-50.00%-33.33%0.00%-75.00%0.00%0.00%0.00%25.00%-20.00%0.00%0.00%-40.00%-33.33%0.00%0.00%-20.00%-20.00%-25.00%25.00%25.00%0.00%-42.86%-16.67%-16.67%-16.67%0.00%-16.67%0.00%-
TimingPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap69.36B
Enterprise Value82.64B
Trailing P/E31.40
Forward P/E28.25
PEG Ratio3.77
Price / Sales2.59
Price / Book2.22
EPS0.25
Book Value3.54
Revenue (TTM)26.75B
Gross Profit (TTM)8.89B
EBITDA5.60B
Profit Margin8.39%
Operating Margin15.20%
Return on Equity8.10%
Return on Assets4.38%
Shares Outstanding8.84B
Shares Float3.13B
Beta0.16
Dividend Yield1.40%
Dividend Rate0.11
Payout Ratio64.71%

Dividends

20261×
0.06Mar 27, 2026
20252×
0.05Sep 29, 20250.06Mar 27, 2025
20242×
0.04Sep 27, 20240.06Mar 26, 2024
20233×
0.04Sep 27, 20230.10May 30, 20230.07Mar 30, 2023
20221×
0.06Mar 30, 2022
20211×
0.04Mar 30, 2021
20201×
0.04Mar 30, 2020
20191×
0.03Jun 27, 2019
20181×
0.03Jun 27, 2018
20171×
0.03Jun 28, 2017
20161×
0.03Jun 28, 2016
20151×
0.03Jul 1, 2015
20141×
0.02Jun 26, 2014